Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.4 - $0.61 $373 - $569
933 Added 4.52%
21,572 $11,000
Q4 2023

Feb 13, 2024

SELL
$0.33 - $0.58 $11 - $20
-36 Reduced 0.17%
20,639 $9,000
Q3 2023

May 14, 2024

BUY
$0.37 - $0.99 $13 - $35
36 Added 0.17%
20,675 $7,000
Q3 2023

Nov 14, 2023

SELL
$0.37 - $0.99 $74,123 - $198,329
-200,333 Reduced 90.65%
20,675 $7,000
Q2 2023

May 14, 2024

BUY
$0.78 - $1.28 $115,399 - $189,373
147,948 Added 202.5%
221,008 $183,000
Q2 2023

Aug 14, 2023

BUY
$0.78 - $1.28 $115,399 - $189,373
147,948 Added 202.5%
221,008 $183,000
Q1 2023

May 14, 2024

SELL
$1.1 - $2.95 $888,255 - $2.38 Million
-807,505 Reduced 91.7%
73,060 $88,000
Q1 2023

May 11, 2023

SELL
$1.1 - $2.95 $888,255 - $2.38 Million
-807,505 Reduced 91.7%
73,060 $88,000
Q4 2022

May 14, 2024

SELL
$1.82 - $2.71 $110,777 - $164,949
-60,867 Reduced 6.47%
880,565 $1.77 Million
Q4 2022

Feb 13, 2023

SELL
$1.82 - $2.71 $110,777 - $164,949
-60,867 Reduced 6.47%
880,565 $1.77 Million
Q3 2022

May 14, 2024

SELL
$2.5 - $4.73 $40,072 - $75,817
-16,029 Reduced 1.67%
941,432 $2.35 Million
Q3 2022

Nov 10, 2022

SELL
$2.5 - $4.73 $40,072 - $75,817
-16,029 Reduced 1.67%
941,432 $2.35 Million
Q2 2022

May 14, 2024

BUY
$2.86 - $6.44 $2.68 Million - $6.03 Million
936,822 Added 4539.09%
957,461 $3.66 Million
Q2 2022

Aug 15, 2022

SELL
$2.86 - $6.44 $368,350 - $829,433
-128,794 Reduced 11.86%
957,461 $3.66 Million
Q1 2022

May 16, 2022

BUY
$5.94 - $12.09 $1.14 Million - $2.32 Million
191,784 Added 21.44%
1,086,255 $6.85 Million
Q4 2021

Feb 17, 2022

SELL
$10.45 - $16.9 $95 Million - $154 Million
-9,092,477 Reduced 91.04%
894,471 $10.3 Million
Q4 2021

Feb 14, 2022

BUY
$10.45 - $16.9 $95.4 Million - $154 Million
9,125,918 Added 1059.88%
9,986,948 $115 Million
Q3 2021

Nov 10, 2021

BUY
$10.9 - $27.63 $9.39 Million - $23.8 Million
861,030 New
861,030 $9.64 Million

Others Institutions Holding OMIC

About Singular Genomics Systems, Inc.


  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.52B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.